Beverages - Alcoholic
Compare Stocks
2 / 10Stock Comparison
ABEV vs SAM
Revenue, margins, valuation, and 5-year total return — side by side.
Beverages - Alcoholic
ABEV vs SAM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Beverages - Alcoholic | Beverages - Alcoholic |
| Market Cap | $53.57B | $2.21B |
| Revenue (TTM) | $88.24B | $2.09B |
| Net Income (TTM) | $15.50B | $-61M |
| Gross Margin | 51.4% | 45.2% |
| Operating Margin | 27.0% | -3.8% |
| Forward P/E | 3.4x | 20.9x |
| Total Debt | $5.35B | $38M |
| Cash & Equiv. | $18.64B | $223M |
ABEV vs SAM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ambev S.A. (ABEV) | 100 | 148.5 | +48.5% |
| The Boston Beer Com… (SAM) | 100 | 36.5 | -63.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ABEV vs SAM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ABEV carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 1 yrs, beta 0.43, yield 7.7%
- Lower P/E (3.4x vs 20.9x)
- 17.6% margin vs SAM's -2.9%
SAM is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 3.7%, EPS growth 95.5%, 3Y rev CAGR -0.0%
- 33.8% 10Y total return vs ABEV's -11.3%
- Lower volatility, beta 0.29, Low D/E 4.5%, current ratio 1.65x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.7% revenue growth vs ABEV's -1.4% | |
| Value | Lower P/E (3.4x vs 20.9x) | |
| Quality / Margins | 17.6% margin vs SAM's -2.9% | |
| Stability / Safety | Beta 0.29 vs ABEV's 0.43, lower leverage | |
| Dividends | 7.7% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +45.0% vs SAM's -14.7% | |
| Efficiency (ROA) | 10.7% ROA vs SAM's -5.0%, ROIC 22.3% vs 15.5% |
ABEV vs SAM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ABEV leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ABEV is the larger business by revenue, generating $88.2B annually — 42.1x SAM's $2.1B. ABEV is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to SAM's -2.9%. On growth, SAM holds the edge at +1.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $88.2B | $2.1B |
| EBITDAEarnings before interest/tax | $30.6B | $14M |
| Net IncomeAfter-tax profit | $15.5B | -$61M |
| Free Cash FlowCash after capex | $19.8B | $191M |
| Gross MarginGross profit ÷ Revenue | +51.4% | +45.2% |
| Operating MarginEBIT ÷ Revenue | +27.0% | -3.8% |
| Net MarginNet income ÷ Revenue | +17.6% | -2.9% |
| FCF MarginFCF ÷ Revenue | +22.5% | +9.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -8.2% | +1.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -9.7% | -7.4% |
Valuation Metrics
Evenly matched — ABEV and SAM each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 17.1x trailing earnings, ABEV trades at a 18% valuation discount to SAM's 20.9x P/E. On an enterprise value basis, ABEV's 8.6x EV/EBITDA is more attractive than SAM's 8.6x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $53.6B | $2.2B |
| Enterprise ValueMkt cap + debt − cash | $50.9B | $2.0B |
| Trailing P/EPrice ÷ TTM EPS | 17.11x | 20.87x |
| Forward P/EPrice ÷ next-FY EPS est. | 3.37x | 20.92x |
| PEG RatioP/E ÷ EPS growth rate | 2.60x | — |
| EV / EBITDAEnterprise value multiple | 8.62x | 8.62x |
| Price / SalesMarket cap ÷ Revenue | 3.00x | 1.06x |
| Price / BookPrice ÷ Book value/share | 2.99x | 2.58x |
| Price / FCFMarket cap ÷ FCF | 13.32x | 10.27x |
Profitability & Efficiency
ABEV leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
ABEV delivers a 16.8% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-7 for SAM. SAM carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to ABEV's 0.06x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +16.8% | -7.3% |
| ROA (TTM)Return on assets | +10.7% | -5.0% |
| ROICReturn on invested capital | +22.3% | +15.5% |
| ROCEReturn on capital employed | +20.7% | +14.8% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.06x | 0.04x |
| Net DebtTotal debt minus cash | -$13.3B | -$186M |
| Cash & Equiv.Liquid assets | $18.6B | $223M |
| Total DebtShort + long-term debt | $5.3B | $38M |
| Interest CoverageEBIT ÷ Interest expense | 9.97x | — |
Total Returns (Dividends Reinvested)
ABEV leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ABEV five years ago would be worth $13,138 today (with dividends reinvested), compared to $1,860 for SAM. Over the past 12 months, ABEV leads with a +45.0% total return vs SAM's -14.7%. The 3-year compound annual growth rate (CAGR) favors ABEV at 10.6% vs SAM's -12.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +38.9% | +3.3% |
| 1-Year ReturnPast 12 months | +45.0% | -14.7% |
| 3-Year ReturnCumulative with dividends | +35.3% | -33.9% |
| 5-Year ReturnCumulative with dividends | +31.4% | -81.4% |
| 10-Year ReturnCumulative with dividends | -11.3% | +33.8% |
| CAGR (3Y)Annualised 3-year return | +10.6% | -12.9% |
Risk & Volatility
Evenly matched — ABEV and SAM each lead in 1 of 2 comparable metrics.
Risk & Volatility
SAM is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than ABEV's 0.43 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ABEV currently trades 99.4% from its 52-week high vs SAM's 78.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.43x | 0.29x |
| 52-Week HighHighest price in past year | $3.45 | $264.46 |
| 52-Week LowLowest price in past year | $2.10 | $185.34 |
| % of 52W HighCurrent price vs 52-week peak | +99.4% | +78.0% |
| RSI (14)Momentum oscillator 0–100 | 71.1 | 28.6 |
| Avg Volume (50D)Average daily shares traded | 23.8M | 203K |
Analyst Outlook
ABEV leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates ABEV as "Hold" and SAM as "Hold". Consensus price targets imply 19.6% upside for SAM (target: $247) vs -17.2% for ABEV (target: $3). ABEV is the only dividend payer here at 7.70% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $2.84 | $246.86 |
| # AnalystsCovering analysts | 14 | 31 |
| Dividend YieldAnnual dividend ÷ price | +7.7% | — |
| Dividend StreakConsecutive years of raises | 1 | 0 |
| Dividend / ShareAnnual DPS | $1.30 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | +9.3% |
ABEV leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.
ABEV vs SAM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ABEV or SAM a better buy right now?
For growth investors, The Boston Beer Company, Inc.
(SAM) is the stronger pick with 3. 7% revenue growth year-over-year, versus -1. 4% for Ambev S. A. (ABEV). Ambev S. A. (ABEV) offers the better valuation at 17. 1x trailing P/E (3. 4x forward), making it the more compelling value choice. Analysts rate Ambev S. A. (ABEV) a "Hold" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ABEV or SAM?
On trailing P/E, Ambev S.
A. (ABEV) is the cheapest at 17. 1x versus The Boston Beer Company, Inc. at 20. 9x. On forward P/E, Ambev S. A. is actually cheaper at 3. 4x.
03Which is the better long-term investment — ABEV or SAM?
Over the past 5 years, Ambev S.
A. (ABEV) delivered a total return of +31. 4%, compared to -81. 4% for The Boston Beer Company, Inc. (SAM). Over 10 years, the gap is even starker: SAM returned +33. 8% versus ABEV's -11. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ABEV or SAM?
By beta (market sensitivity over 5 years), The Boston Beer Company, Inc.
(SAM) is the lower-risk stock at 0. 29β versus Ambev S. A. 's 0. 43β — meaning ABEV is approximately 49% more volatile than SAM relative to the S&P 500. On balance sheet safety, The Boston Beer Company, Inc. (SAM) carries a lower debt/equity ratio of 4% versus 6% for Ambev S. A. — giving it more financial flexibility in a downturn.
05Which is growing faster — ABEV or SAM?
By revenue growth (latest reported year), The Boston Beer Company, Inc.
(SAM) is pulling ahead at 3. 7% versus -1. 4% for Ambev S. A. (ABEV). On earnings-per-share growth, the picture is similar: The Boston Beer Company, Inc. grew EPS 95. 5% year-over-year, compared to 8. 8% for Ambev S. A.. Over a 3-year CAGR, ABEV leads at 3. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ABEV or SAM?
Ambev S.
A. (ABEV) is the more profitable company, earning 17. 6% net margin versus 5. 2% for The Boston Beer Company, Inc. — meaning it keeps 17. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ABEV leads at 25. 3% versus 6. 9% for SAM. At the gross margin level — before operating expenses — ABEV leads at 51. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ABEV or SAM more undervalued right now?
On forward earnings alone, Ambev S.
A. (ABEV) trades at 3. 4x forward P/E versus 20. 9x for The Boston Beer Company, Inc. — 17. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SAM: 19. 6% to $246. 86.
08Which pays a better dividend — ABEV or SAM?
In this comparison, ABEV (7.
7% yield) pays a dividend. SAM does not pay a meaningful dividend and should not be held primarily for income.
09Is ABEV or SAM better for a retirement portfolio?
For long-horizon retirement investors, Ambev S.
A. (ABEV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 43), 7. 7% yield). Both have compounded well over 10 years (ABEV: -11. 3%, SAM: +33. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ABEV and SAM?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ABEV is a mid-cap deep-value stock; SAM is a small-cap quality compounder stock. ABEV pays a dividend while SAM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.